Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny

Blood

Volumn 96, Issue 3, 2000, Pages 894-901

  Klug, Christopher A ^a,b   Cheshier, Samuel ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROVIRUS; RETROVIRUS; VIRUS INACTIVATION;

EID: 0034254827     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.894.015k35_894_901     Document Type: Article

References (44)

1. Retroviral stem cell gene therapy
2. The basic science of gene therapy
3. Human gene therapy comes of age
4. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
5. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
6. + cells from the bone marrow of human immunodeficiency virus-1-infected children
7. A majority of mice show long-term expression of a human β-globin gene after retrovirus transfer into hematopoietic stem cells
8. Factors affecting the transduction of pluripotent hematopoietic stem cells: Long-term expression of a human adenosine deaminase gene in mice
9. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells
10. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector
11. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
12. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer
13. High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector
14. The long-term re-populating subset of hematopoietic stem cells is deterministic and isolatable by phenotype
15. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity
16. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells
17. Production of high-titer helper-free retroviruses by transient transfection
18. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells
19. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
20. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment
21. In vivo proliferation and cell cycle kinetics of long-term self- renewing hematopoietic stem cells
22. Identification of a lineage of multipotent hematopoietic progenitors
23. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells
24. De novo methylation and expression of retroviral genomes during mouse embryogenesis
25. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position
26. Cytosine methylation and the ecology of intragenomic parasites
27. Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice
28. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes
29. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
30. Acceptor sites for retroviral integration map near DNase I- hypersensitive sites in chromatin
31. Retrovirus integration and chromatin structure: Moloney murine leukemia virus integration sites map near DNase I-hypersensitive sites
32. Transcriptionally active genome regions are preferred integration sites for retrovirus integration
33. Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions
34. Histone acetylation in chromatin structure and transcription
35. High transdominant RevM10 protein levels are required to inhibit replication in cell lines and primary T cells: Implication for gene therapy of AIDS
36. T cell activation modulates retrovirus-mediated gene expression
37. + cells in ADA-deficient SCID neonates
38. Versatile retroviral vectors for potential use in gene therapy
39. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells
40. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lymphomyeloid progeny
41. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
42. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
43. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen